KRSA insider transactions
Korsana Biosciences Inc. (KRSA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
KRSA insiders
Everyone who has filed a Form 3, 4, 5 or 144 at Korsana Biosciences Inc., latest first. Follow anyone to get their next filing.
- Michelle Patricia PerniceDirector, since September 2026
- Nimish P ShahDirector, since September 2026
- Fairmount Funds Management LLCDirector, 10% owner, since September 2026
- Andrew GottesdienerDirector, since September 2026
- Jonathan ViolinOfficer, Director, since September 2026
- Matthew James LeoniChief Medical Officer, since September 2026
- Heidi HensonDirector, since September 2026
- Mark J. VignolaChief Financial Officer, since September 2026
- Rhonda M. ChickoChief Financial Officer, since March 2024
- Regina Margaret GraulPresident, Director, since December 2023
- Peter M HechtDirector, 10% owner+$2.43M
- Michael J HigginsDirector, since November 2023
- Slate Path Capital LP10% owner+$3M-$555K
- Dina KatabiDirector, since November 2023
- Terrance McguireDirector+$300K-$27.16
- Errol B DesouzaDirector
- Steven HymanDirector, since July 2022
- Michael MendelsohnDirector
- George H ConradesDirector
- Marsha FanucciDirector
- Stephanie LovellDirector
- Ole IsacsonDirector
- Andreas BuschOfficer
- Anjeza GjinoOfficer-$7,296
- Cheryl GaultOfficer
- Kevin ChurchwellDirector
- Christopher I WrightOfficer-$10.5K
Recent Form 3, 4, and 5 filings for KRSA
No insider items on the wire yet for KRSA. View all KRSA news.